[GlobeNewswire] - NEW YORK -- NeoStem, Inc. (NYSE MKT:NBS) ("NeoStem" or the "Company"), a leader in the emerging cellular therapy market, today announced that the Company and its subsidiary, Progenitor ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment